Artiva Biotherapeutics, Inc. (ARTV) Insider Trading

Name: Artiva Biotherapeutics, Inc. (ARTV) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 7, 2026): Fred Aslan (Chief Executive Officer): Sale of 23,463 shares, $168.9K.

Get alerted when insiders trade ARTV

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta